explore -WSS

explore

author：comprehensive 2025-09-03 03:20:21 - browse：8

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Court strikes down limits on filming of police in Arizona

knowledge

WSS

Organ transplantation is at a crossroads. Major reform is needed

AbbVie dramatically boosts its spending on lobbying

There’s a way to spot data fakery. All journals should be using it

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Caribou posts encouraging results on off

Telehealth startups are trying to fill the menopause care vacuum

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

explore

At least 13 dead in Texas as scorching temps continue

Organ transplantation is at a crossroads. Major reform is needed

At least 13 dead in Texas as scorching temps continue

Caitlin Bernard's story shows physicians can't shy from advocacy

New air purifier tech could be key to improving indoor air quality

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

A double vaccine crisis is endangering millions of children

Tori Bowie and the unacceptable rates of Black maternal death

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

leisure time

Are infertility treatments 'essential' during the Covid

A double vaccine crisis is endangering millions of children

Death toll from an explosion and collapse of a Paris building in June climbs to 3

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Are infertility treatments 'essential' during the Covid

knowledge

knowledge

explore

leisure time